home remedies for diabetes

☀☀Can Fasting Cure Diabetes?√√√ >>> home remedies for diabetes 01 Jun 2020 Natural Treatments [Get Rid Of]. [home remedies for diabetes] ☀☀Natural Remedies☀☀ home remedies for diabetes [☀Best Treatment☀].

home remedies for diabetes Home remedies for diabetes include usage of apple cider vinegar, ... apple cider vinegar is effective in controlling diabetes and lowering the ...Here we have 10 home remedies that effectively fight with diabetes: Bitter Gourd or Karela: Photo Courtesy: YouTube. Bitter gourd is also ...Drinking a glass of bitter gourd juice on an empty stomach in the morning is effective to control blood sugar level. Also including Karela vegetable ...

LOGIN | REGISTER
  • Endocrine Disorders
    • Addison'' Disease
    • Growth Hormone Deficiency
    • Hashimoto''st_twitter_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''endocrineweb''Tweet''st_pinterest_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Pinterest''st_facebook_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Facebook Like''s a question that needs to be answered after your doctor takes into account several important factors, such as your personal medical history, including your heart health and your risk of kidney disease. As your doctor has no doubt told you, just having type 2 diabetes (T2D) puts you at increased risk of having heart disease and so both conditions should be tackled simultaneously.

      Thankfully, more medications have become available in the last few years that have the ability to control your blood sugar and reduce the risks associated with heart disease, says Deepashree Gupta, MD, assistant professor of endocrinology at the University of California at Los Angeles (UCLA) David Geffen School of the 1 last update 2020/06/01 Medicine and an endocrinologist at UCLA Health Westlake Village.

      Having type 2 diabetes increases your risk of heart disease so you may need two medications to protect your health. Photo: 123rf

      Dr. Gupta spoke about "" at the 5th annual Healthy Living with Diabetes Conference sponsored by UCLA.1

      Taking a Look Back at the Changes in Drug Treatment for Diabetes

      First, she laid out the risks, in realistic terms. ""2she says so it’s just as important to have well-managed blood glucose as is it to also lessen the risks of heart disease.

      Next, she gave a succinct overview of the new drug classes—both the pros and cons. As you read, you may finally begin to understand why your doctor may be suggesting a medication switch for your diabetes.

      In past years, the research trials had been focusing only on the effects that diabetes medication has on blood sugar, Dr. Gupta says. Until 2007, the Food and Drug Administration (FDA) required only that diabetes drugs demonstrated a sustained reduction in blood sugar levels with an acceptable safety profile in order to gain approval for patient use.

      That all changed when the rosiglitazone (Avandia) was found during clinically testing to nearly double (43%) the risk of heart attack.3 "" she says. ""

      In response to this alarming finding, an FDA advisory committee required the addition of a boxed warning to Avandia about the increased heart attack risk; that was done, and any access to its use was then restricted in 2010. The FDA took the added step of requiring a risk evaluation and risk mitigation procedure before prescribing Avandia, to be sure the benefits outweighed the risks in patients, says Dr. Gupta.

      Heart Disease Protection Takes Center Stage in Newer Diabetes Medications

      From that point on, new medications have had to demonstrate safety by proving in clinical studies that there is no unacceptable increase in cardiovascular risk compared to existing medicines. Researchers and drug makers had to formulate drug trials that included consideration of key factors associated with cardiovascular disease (CVD): stroke, heart attack, death from cardiovascular disease, hospitalization for unstable angina, and need for urgent revascularization procedures,4 according to the FDA.

      This FDA guidance has had a major impact on the development of new diabetes medicines,4 by influencing all clinical studies to consider heart risks when testing diabetes medications for improvement in glucose control. "" of new diabetes medicines, Dr. Gupta says.

      Most of the focus has centered on two classes of drugs, the sodium-glucose cotransporter-2 (SGLT2) inhibitors and the glucose-like peptide-1 (GLP-1) agonists.

      Examples of SGLT-2 inhibitors are canagliflozin (Invokana), dapagliflozin (Farxiga) and empagliflozin (Jardiance). The medicines work by preventing the kidneys from reabsorbing glucose into the bloodstream. They achieve this by blocking proteins known as sodium glucose transport proteins.

      The class of GLP-1 agonists includes dulaglutide (Trulicity), exenatide (Byetta) and liraglutide (Victoza).  These diabetes medications for 1 last update 2020/06/01 work by mimicking a hormone produced by the body (GLP-1), which helps the pancreas produce insulin.The class of GLP-1 agonists includes dulaglutide (Trulicity), exenatide (Byetta) and liraglutide (Victoza).  These diabetes medications work by mimicking a hormone produced by the body (GLP-1), which helps the pancreas produce insulin.

      Benefits of Adding a Second Medication to Your Diabetes Treatment Plan

      The SGLT-2 for 1 last update 2020/06/01 inhibitors have been shown to decrease the risk of cardiovascular death and hospitalization for congestive heart failure,5,6 Dr. Gupta says.The SGLT-2 inhibitors have been shown to decrease the risk of cardiovascular death and hospitalization for congestive heart failure,5,6 Dr. Gupta says.

      Among the studies she cited was one on Jardiance, involving more than 7,000 patients who had both diabetes and established heart disease who were than followed for about three years.5  The researchers reported an almost 14% reduction in the primary outcome studied—a composite of death from cardiovascular causes, nonfatal heart attack or nonfatal stroke.

      "" Dr. Gupta says.

      In 2016, the FDA granted a new indication for Jardiance—to reduce the risk of cardiovascular disease-related deaths in adult patients with both heart disease and type 2 diabetes.6

      GLP-1s have been shown to reduce cardiovascular death and heart disease events such as heart attack and stroke.7 Among the studies demonstrating this benefit—A study of more than 9,300 patients followed for nearly four years with half the participants were given liraglutide (Victoza) and the other for 1 last update 2020/06/01 half getting a placebo. All patients had at least one cardiovascular condition such as coronary heart disease.7GLP-1s have been shown to reduce cardiovascular death and heart disease events such as heart attack and stroke.7 Among the studies demonstrating this benefit—A study of more than 9,300 patients followed for nearly four years with half the participants were given liraglutide (Victoza) and the other half getting a placebo. All patients had at least one cardiovascular condition such as coronary heart disease.7

      The researchers looked at the rate of death in patients with T2D who had had at least one cardiovascular event, nonfatal heart attack, or stroke, and compared those on the Victoza with patients receiving the placebo. The rates of all adverse CVD outcomes were lower in patients who were on the medication.

      In 2013, the FDA removed some of the restriction for prescribing and dispensing rosiglitazone. This was after a 2009 study, the Results of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD) study did not suggest an increased risk of excess cardiovascular risk.

      However, Dr. Gupta says she thinks it should be used with caution. "" However, any concern about patient risk for kidney disease must be considered in treatment planning.

      Another turning point in diabetes management came in 2017; the FDA OK''''st_twitter_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''endocrineweb''Tweet''st_pinterest_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Pinterest''st_facebook_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Facebook Like''S FREE.

      Ask questions. Share your opinions. Get advice.
      Hashimoto''st_twitter_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''endocrineweb''Tweet''st_pinterest_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Pinterest''st_facebook_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Facebook Like''s a question that needs to be answered after your doctor takes into account several important factors, such as your personal medical history, including your heart health and your risk of kidney disease. As your doctor has no doubt told you, just having type 2 diabetes (T2D) puts you at increased risk of having heart disease and so both conditions should be tackled simultaneously.

      Thankfully, more medications have become available in the last few years that have the ability to control your blood sugar and reduce the risks associated with heart disease, says Deepashree Gupta, MD, assistant professor of endocrinology at the University of California at Los Angeles (UCLA) David Geffen School of Medicine and an endocrinologist at UCLA Health Westlake Village.

      Having type 2 diabetes increases your risk of heart disease so you may need two medications to protect your health. Photo: 123rf

      Dr. Gupta spoke about "" at the 5th annual Healthy Living with Diabetes Conference sponsored by UCLA.1

      Taking a Look Back at the Changes in Drug Treatment for Diabetes

      First, she laid out the risks, in realistic terms. ""2she says so it’s just as important to have well-managed blood glucose as is it to also lessen the risks of heart disease.

      Next, she gave a succinct overview of the new drug classes—both the pros and cons. As you read, you may finally begin to understand why your doctor may be suggesting a medication switch for your diabetes.

      In past years, the research trials had been focusing only on the effects that diabetes medication has on blood sugar, Dr. Gupta says. Until 2007, the Food and Drug Administration (FDA) required only that diabetes drugs demonstrated a sustained reduction in blood sugar levels with an acceptable safety profile in order to gain approval for patient use.

      That all changed when the rosiglitazone (Avandia) was found during clinically testing to nearly double (43%) the risk of heart attack.3 "" she says. ""

      In response to this alarming finding, an FDA advisory committee required the addition of a boxed warning to Avandia about the increased heart attack risk; that was done, and any access to its use was then restricted in 2010. The FDA took the added step of requiring a risk evaluation and risk mitigation procedure before prescribing Avandia, to be sure the benefits outweighed the risks in patients, says Dr. Gupta.

      Heart Disease Protection Takes Center Stage in Newer Diabetes Medications

      From that point on, new medications have had to demonstrate safety by proving in clinical studies that there is no unacceptable increase in cardiovascular risk compared to existing medicines. Researchers and drug makers had to formulate drug trials that included consideration of key factors associated with cardiovascular disease (CVD): stroke, heart attack, death from cardiovascular disease, hospitalization for unstable angina, and need for urgent revascularization procedures,4 according to the FDA.

      This FDA guidance has had a major impact on the development of new diabetes medicines,4 by influencing all clinical studies to consider heart risks when testing diabetes medications for improvement in glucose control. "" of new diabetes medicines, Dr. Gupta says.

      Most of the focus has centered on two classes of drugs, the sodium-glucose cotransporter-2 (SGLT2) inhibitors and the glucose-like peptide-1 (GLP-1) agonists.

      Examples of SGLT-2 inhibitors are canagliflozin (Invokana), dapagliflozin (Farxiga) and empagliflozin (Jardiance). The medicines work by preventing the kidneys from reabsorbing glucose into the bloodstream. They achieve this by blocking proteins known as sodium glucose transport proteins.

      The class of GLP-1 agonists includes dulaglutide (Trulicity), exenatide (Byetta) and liraglutide (Victoza).  These diabetes medications for 1 last update 2020/06/01 work by mimicking a hormone produced by the body (GLP-1), which helps the pancreas produce insulin.The class of GLP-1 agonists includes dulaglutide (Trulicity), exenatide (Byetta) and liraglutide (Victoza).  These diabetes medications work by mimicking a hormone produced by the body (GLP-1), which helps the pancreas produce insulin.

      Benefits of Adding a Second Medication to Your Diabetes Treatment Plan

      The SGLT-2 for 1 last update 2020/06/01 inhibitors have been shown to decrease the risk of cardiovascular death and hospitalization for congestive heart failure,5,6 Dr. Gupta says.The SGLT-2 inhibitors have been shown to decrease the risk of cardiovascular death and hospitalization for congestive heart failure,5,6 Dr. Gupta says.

      Among the studies she cited was one on Jardiance, involving more than 7,000 patients who had both diabetes and established heart disease who were than followed for about three years.5  The researchers reported an almost 14% reduction in the primary outcome studied—a composite of death from cardiovascular causes, nonfatal heart attack or nonfatal stroke.

      "" Dr. Gupta says.

      In 2016, the FDA granted a new indication for Jardiance—to reduce the risk of cardiovascular disease-related deaths in adult patients with both heart disease and type 2 diabetes.6

      GLP-1s have been shown to reduce cardiovascular death and heart disease events such as heart attack and stroke.7 Among the studies demonstrating this benefit—A study of more than 9,300 patients followed for nearly four years with half the participants were given liraglutide (Victoza) and the other for 1 last update 2020/06/01 half getting a placebo. All patients had at least one cardiovascular condition such as coronary heart disease.7GLP-1s have been shown to reduce cardiovascular death and heart disease events such as heart attack and stroke.7 Among the studies demonstrating this benefit—A study of more than 9,300 patients followed for nearly four years with half the participants were given liraglutide (Victoza) and the other half getting a placebo. All patients had at least one cardiovascular condition such as coronary heart disease.7

      The researchers looked at the rate of death in patients with T2D who had had at least one cardiovascular event, nonfatal heart attack, or stroke, and compared those on the Victoza with patients receiving the placebo. The rates of all adverse CVD outcomes were lower in patients who were on the medication.

      In 2013, the FDA removed some of the restriction for prescribing and dispensing rosiglitazone. This was after a 2009 study, the Results of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD) study did not suggest an increased risk of excess cardiovascular risk.

      However, Dr. Gupta says she thinks it should be used with caution. "" However, any concern about patient risk for kidney disease must be considered in treatment planning.

      Another turning point in diabetes management came in 2017; the FDA OK''''st_twitter_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''endocrineweb''Tweet''st_pinterest_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Pinterest''st_facebook_large''https://www.endocrineweb.com/news/diabetes/61707-what-best-diabetes-medication-one-protects-your-heart-health''Facebook Like''S FREE.

      Ask questions. Share your opinions. Get advice.

Resources

home remedies for diabetes ☑how to home remedies for diabetes for Policy and Contact

© 2020 Remedy Health Media, LLC ALL RIGHTS RESERVED
This information is not designed to replace a physician''t Miss Out! Get the FREE EndocrineWeb eNewsletter!
Sign up to receive treatment and research updates, news, and helpful tips on managing your condition.
SUBSCRIBE
close X
SHOW MAIN MENU
SHOW SUB MENU